Cerenome (CNSY) Cash from Financing Activities (2010 - 2026)
Powered by 
Analysis
Cerenome (CNSY) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | -426.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | -1.22 Bn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | 14.00 Mn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | 2.42 Bn |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | -6.05 Mn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 36.24 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | -273.15 Mn |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 27.18 Mn |
| 10 | Cerenome | 20.42 Mn | 11.83 Mn | - | 1.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.11 Mn |
| Mar 31, 2026 | 9.04 Mn |
| Dec 31, 2025 | 2.80 Mn |
| Sep 30, 2025 | 12.31 Mn |
| Jun 30, 2025 | 2.80 Mn |
| Mar 31, 2025 | 12.41 Mn |
| Jun 30, 2024 | 6.96 Mn |
| Mar 31, 2024 | -776,000.00 |
| Dec 31, 2023 | -529,000.00 |
| Sep 30, 2023 | 2.52 Mn |
| Jun 30, 2023 | 961,000.00 |
| Mar 31, 2023 | 493,000.00 |
| Dec 31, 2022 | 99,000.00 |
| Sep 30, 2022 | 6.43 Mn |
| Jun 30, 2022 | -371,000.00 |
| Mar 31, 2022 | 7.29 Mn |
| Dec 31, 2021 | -258,000.00 |
| Sep 30, 2021 | 6.37 Mn |
| Jun 30, 2021 | 5.11 Mn |
| Mar 31, 2021 | 9.19 Mn |